Stay updated with breaking news from Nasdaq Dcph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) have been given a consensus rating of “Moderate Buy” by the ten ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and six have assigned a buy recommendation to […]
Teacher Retirement System of Texas purchased a new stake in shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) during the 3rd quarter, HoldingsChannel reports. The firm purchased 12,935 shares of the company’s stock, valued at approximately $239,000. Other hedge funds and other institutional investors have also added to or reduced their stakes in the […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities researchers at SVB Leerink reduced their FY2026 earnings per share estimates for Deciphera Pharmaceuticals in a note issued to investors on Wednesday, January 4th. SVB Leerink analyst A. Berens now expects that the company will earn $3.38 per share for the year, down from their previous […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) insider Jama Pitman sold 1,298 shares of the company’s stock in a transaction dated Thursday, June 16th. The shares were sold at an average price of $10.75, for a total transaction of $13,953.50. Following the completion of the transaction, the insider now directly owns 36,661 shares in the […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) EVP Matthew L. Sherman sold 1,768 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Thursday, June 16th. The shares were sold at an average price of $10.75, for a total transaction of $19,006.00. Following the sale, the executive vice president now owns 76,884 shares of […]